Twenty-three people have died since October in ICE custody, as advocates warn about overcrowding and health care access.

A House Ethics Committee calculation tool indicates that at least $4.2 million worth of the Oklahoma congressman’s personal stock trades were made a few days past a federal deadline.

Steve Emt and Laura Dwyer represent the U.S. in the Paralympics' new mixed doubles wheelchair curling event. They could bring home Team USA's first wheelchair curling medal ever.

More than a week of the U.S. and Israel's war against Iran has dragged in global powers, upended the world's energy and transport sectors, and brought chaos to usually peaceful areas of the region.

Voting ends Tuesday night in the district that former Rep. Marjorie Taylor Greene left this year after a feud with President Trump. It's unclear if his pick will win her spot.

President Trump provided conflicting messages about when the U.S. and Israel's war with Iran will end. And, NPR investigates how late convicted sex offender Jeffrey Epstein leveraged ties with ...

The case of Khalil, who was detained last March, sits at the vanguard of a battle of immigrants' due process and civil rights, and the Trump administration's mass detention and deportation policies.

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.

The Constitution gives Congress the power to declare war, but presidents assert broad authority over use of force and the military. Congress has done little to push back.

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

Australia has granted asylum to five members of the Iranian women's soccer team who were in the country for a tournament when the Iran war began.

Three brothers, including two of the nation's most successful luxury real estate brokers, were convicted of sex trafficking Monday after a five-week trial.